Cumulative neonatal oxygen exposure predicts response of adult mice infected with influenza A virus

Pediatric Pulmonology

Volumn 50, Issue 3, 2015, Pages 222-230

  Maduekwe, Echezona T ^a   Buczynsk, Bradley W ^a   Yee, Min ^a   Rangasamy, Tiruamalai ^a   Stevens, Timothy P ^a   Lawrence, B Paige ^a   O'Reilly, Michael A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Hyperoxia; Infections: pneumonia; Prematurity; TB; Viral

Indexed keywords

ELASTIN; OXYGEN;

ADULT; AMBIENT AIR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPOSURE; FEMALE; INFLUENZA A; INFLUENZA VIRUS A; LOW BIRTH WEIGHT; LUNG ALVEOLUS; LUNG DEVELOPMENT; LUNG FIBROSIS; MORBIDITY; MOUSE; NEWBORN; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESPIRATORY TRACT INFLAMMATION; RISK ASSESSMENT; SIBLING;

EID: 84923112377     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23063     Document Type: Article

References (27)

1. Smith CV, Hansen TN, Martin NE, McMicken HW, Elliott SJ. Oxidant stress responses in premature infants during exposure to hyperoxia. Pediatr Res 1993;34:360-365.
2. Davis JM, Auten RL. Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med 2010;15:191-195.
3. Stevens TP, Dylag A, Panthagani I, Pryhuber G, Halterman J. Effect of cumulative oxygen exposure on respiratory symptoms during infancy among VLBW infants without bronchopulmonary dysplasia. Pediatr Pulmonol 2010;45:371-379.
4. Yee M, Chess PR, McGrath-Morrow SA, Wang Z, Gelein R, Zhou R, Dean DA, Notter RH, O'Reilly MA. Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity. Am J Physiol Lung Cell Mol Physiol 2009;297:L641-L649.
5. O'Reilly MA, Marr SH, Yee M, McGrath-Morrow SA, Lawrence BP. Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza Avirus. Am J Respir Crit Care Med 2008;177:1103-1110.
6. Buczynski BW, Yee M, Paige Lawrence B, O'Reilly MA. Lung development and the host response to influenza Avirus are altered by different doses of neonatal oxygen in mice. Am J Physiol Lung Cell Mol Physiol 2012;302:L1078-L1087.
7. Oertelt-Prigione S. The influence of sex and gender on the immune response. Autoimmun Rev 2011; 9.
8. Yee M, Vitiello PF, Roper JM, Staversky RJ, Wright TW, McGrath-Morrow SA, Maniscalco WM, Finkelstein JN, O'Reilly MA. Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung development. Am J Physiol Lung Cell Mol Physiol 2006;291:L1101-L1111.
9. McGrath-Morrow SA, Cho C, Soutiere S, Mitzner W, Tuder R. The effect of neonatal hyperoxia on the lung of p21Waf1/Cip1/Sdi1-deficient mice. Am J Respir Cell Mol Biol 2004;30: 635-640.
10. Bates JH, Davis GS, Majumdar A, Butnor KJ, Suki B. Linking parenchymal disease progression to changes in lung mechanical function by percolation. Am J Respir Crit Care Med 2007;176: 617-623.
11. Sjostedt S, Rooth G, Caligara F. The oxygen tension of the amniotic fluid. Am J Obstet Gynecol 1958;76:1226-1230.
12. Frank L. Developmental aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med 1991;11:463-494.
13. Gladstone IM, Jr., Levine RL. Oxidation of proteins in neonatal lungs. Pediatrics 1994;93:764-768.
14. Moison RM, Palinckx JJ, Roest M, Houdkamp E, Berger HM. Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies. Lancet 1993;341:79-82.
15. Jobe AH, Kallapur SG. Long term consequences of oxygen therapy in the neonatal period. Semin Fetal Neonatal Med 2010; 15:230-235.
16. Buczynski BW, Maduekwe ET, O'Reilly MA. The role of hyperoxia in the pathogenesis of experimental BPD. Semin Perinatol 2013;37:69-78.
17. Johnston CJ, Stripp BR, Piedbeouf B, Wright TW, Mango GW, Reed CK, Finkelstein JN. Inflammatory and epithelial responses in mouse strains that differ in sensitivity to hyperoxic injury. Exp Lung Res 1998;24:189-202.
18. Tryka AF, Witschi H, Gosslee DG, McArthur AH, Clapp NK. Patterns of cell proliferation during recovery from oxygen injury. Species differences. Am Rev Respir Dis 1986;133:1055-1059.
19. Nold MF, Mangan NE, Rudloff I, Cho SX, Shariatian N, Samarasinghe TD, Skuza EM, Pedersen J, Veldman A, Berger PJ, Nold-Petry CA. Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia. Proc Natl Acad Sci USA 2013;110:14384-14389.
20. Doyle LW, Anderson PJ. Adult outcome of extremely preterm infants. Pediatrics 2010;126:342-351.
21. Euser AM, de Wit CC, Finken MJ, Rijken M, Wit JM. Growth of preterm born children. Horm Res 2008;70:319-328.
22. Khwaja O, Volpe JJ. Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed 2008;93: F153-F161.
23. Doyle LW, Faber B, Callanan C, Morley R. Blood pressure in late adolescence and very low birth weight. Pediatrics 2003;111: 252-257.
24. Maeda Y, Dave V, Whitsett JA. Transcriptional control of lung morphogenesis. Physiol Rev 2007;87:219-244.
25. Finer N, Leone T. Oxygen saturation monitoring for the preterm infant: The evidence basis for current practice. Pediatr Res 2009; 65:375-380.
26. Parad RB, Allred EN, Rosenfeld WN, Davis JM. Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase. Neonatology 2012;102:139-144.
27. Davis JM, Parad RB, Michele T, Allred E, Price A, Rosenfeld W. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 2003;111:469-476.